TR
/
EN
TABLE OF CONTENTS
Members
Message from the Chairperson & Secretary General
Board of Directors and Board of Auditors
AIFD Working Bodies
Pharma Industry Statistics and Key Figures
Innovation, Turkey and AIFD in 2020
Health and Development
Human and Health
Innovation
Sector and Economy
AIFD in the Press
HUMAN AND HEALTH
Access to Innovation
The availability and average delay times (year) of innovative medicines based on top 10 treatment areas, 2010-17
Reimbursement Process
Our Proposals For Structural Changes In The Reimbursement System
Areas Where Quick Solutions Can Be Implemented In Reimbursement System Procedures
Alternative Reimbursement System
Early Access
Other Problems With Access – Visibility of Prices
AIFD Patients and Patient Associations Initiative
Ethics, compliance and promotion
Transfers of Value to Healthcare Professionals
IFPMA and EFPIA Relations on Ethics and Compliance